期刊文献+

Studied microRNA gene expression in human hepatocellular carcinoma by micro RNA microarray techniques 被引量:6

Studied microRNA gene expression in human hepatocellular carcinoma by micro RNA microarray techniques
下载PDF
导出
摘要 AIM: To achieve a better understanding of the molecular mechanisms of micro RNA expression changes involved in hepatocellular carcinoma.METHODS: In this research process, patients were not treated with antivirals, immunosuppressants or immunomodulators for at least 6 mo before collecting serum. The study population was composed of 35 outpatient hepatitis B virus(HBV) cases and 12 healthy control cases from the Affiliated Hospital of Inner Mongolia Medical University(Inner Mongolia, China) from July 2013 to April 2014. The 35 HBV cases were divided into two groups: a hepatocirrhosis group with 20 cases and a liver cancer group with 15 cases. All 35 cases carried HBs Ag. The diagnostic criteria followed the European Association for the Study of the Liver 2012(EASL2012) standards. Micro RNA(mi RNA) was extracted from a control group of patients, a group with hepatocirrhosis and a group with liver cancer and its quality was analyzed using the human V2 micro RNA expression beadchip. Cluster analysis and a radar chart were then applied to the mi RNA changes.RESULTS: The mi RNA-qualified rate of human serum samples was 93%. The concentration of a single sample was > 200 ng/μL and the volume was > 5 μL.All mi RNA serum samples were uncontaminated by the genome. The Mann-Whitney test showed significant differences in mi RNA between each group, with a detection P-value of < 0.05. Illumina software was set up with Diff Score set to ± 13, meaning that P = 0.001.There were significant changes in mi RNA expression between the three groups. mi RNA-183 was the most up-regulated, followed by mi RNA-373. mi RNA-129 and mi RNA-188 were both strongly down-regulated and mi RNA-378 was down-regulated a small amount. The liver cancer group had greater changes, which indicated that changes in mi RNA expression levels were caused by hepatocirrhosis. The liver cancer disease course then further increased these changes. In the pentagon created by these five mi RNAs, three groups showed significant deviation. The liver cancer group had a bigger deviation trend. The chart indicated that mi RNA expression changes occurred in the hepatocirrhosis group, which increased in the liver cancer disease course and were irreversible.CONCLUSION: There was a significant relationship between the irreversible up-regulation of mi RNA-183/373 and down-regulation of mi RNA-129/188/378 and incidences of hepatocirrhosis and liver cancer. AIM: To achieve a better understanding of the molecular mechanisms of micro RNA expression changes involved in hepatocellular carcinoma.METHODS: In this research process, patients were not treated with antivirals, immunosuppressants or immunomodulators for at least 6 mo before collecting serum. The study population was composed of 35 outpatient hepatitis B virus(HBV) cases and 12 healthy control cases from the Affiliated Hospital of Inner Mongolia Medical University(Inner Mongolia, China) from July 2013 to April 2014. The 35 HBV cases were divided into two groups: a hepatocirrhosis group with 20 cases and a liver cancer group with 15 cases. All 35 cases carried HBs Ag. The diagnostic criteria followed the European Association for the Study of the Liver 2012(EASL2012) standards. Micro RNA(mi RNA) was extracted from a control group of patients, a group with hepatocirrhosis and a group with liver cancer and its quality was analyzed using the human V2 micro RNA expression beadchip. Cluster analysis and a radar chart were then applied to the mi RNA changes.RESULTS: The mi RNA-qualified rate of human serum samples was 93%. The concentration of a single sample was > 200 ng/μL and the volume was > 5 μL.All mi RNA serum samples were uncontaminated by the genome. The Mann-Whitney test showed significant differences in mi RNA between each group, with a detection P-value of < 0.05. Illumina software was set up with Diff Score set to ± 13, meaning that P = 0.001.There were significant changes in mi RNA expression between the three groups. mi RNA-183 was the most up-regulated, followed by mi RNA-373. mi RNA-129 and mi RNA-188 were both strongly down-regulated and mi RNA-378 was down-regulated a small amount. The liver cancer group had greater changes, which indicated that changes in mi RNA expression levels were caused by hepatocirrhosis. The liver cancer disease course then further increased these changes. In the pentagon created by these five mi RNAs, three groups showed significant deviation. The liver cancer group had a bigger deviation trend. The chart indicated that mi RNA expression changes occurred in the hepatocirrhosis group, which increased in the liver cancer disease course and were irreversible.CONCLUSION: There was a significant relationship between the irreversible up-regulation of mi RNA-183/373 and down-regulation of mi RNA-129/188/378 and incidences of hepatocirrhosis and liver cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第44期12605-12611,共7页 世界胃肠病学杂志(英文版)
基金 Supported by Inner Mongolia Medical College Millions of Science and Technology Project in 2011,No.NY2011bw004 the 2010 Inner Mongolia Health Bureau of Medical and Health Research Project,No.2010038 Scientific Research Projects of the Inner Mongolia Autonomous Region High School in 2013,No.NJZY13416
关键词 HEPATOCELLULAR CARCINOMA Micro RNA EXPRESSION Micr Hepatocellular carcinoma Micro RNA Expression Micr
  • 相关文献

参考文献17

  • 1Yusuke Shimakawa,Maud Lemoine,Christian Bottomley,Harr Freeya Njai,Gibril Ndow,Abdoulie Jatta,Saydiba Tamba,Lamin Bojang,Makie Taal,Ousman Nyan,Umberto D’Alessandro,Ramou Njie,Mark Thursz,Andrew J. Hall.Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case–control study in The Gambia[J]. Liver Int . 2015 (10)
  • 2S. B. Paul,Shalimar,V. Sreenivas,S. R. Gamanagatti,H. Sharma,E. Dhamija,S. K. Acharya.Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction[J]. Aliment Pharmacol Ther . 2015 (10)
  • 3Chiao‐Ling Li,Kun‐Huei Yeh,Wan‐Hsin Liu,Chi‐Ling Chen,Ding‐Shinn Chen,Pei‐Jer Chen,Shiou‐Hwei Yeh.Elevated p53 promotes the processing of miR‐18a to decrease estrogen receptor‐α in female hepatocellular carcinoma[J]. Int. J. Cancer . 2015 (4)
  • 4Hoang van Tong,C. Thomas Bock,Thirumalaisamy P. Velavan.Genetic insights on host and hepatitis B virus in liver diseases[J]. Mutation Research-Reviews in Mutation Research . 2014
  • 5Yunpeng Shi,Guoyue Lv,Zhe Chu,Liling Piao,Xingkai Liu,Tuo Wang,Yanfang Jiang,Ping Zhang.Identification of natural splice variants of SAMHD1 in virus-infectedHCC[J]. Oncology Reports . 2014 (2)
  • 6Premashis Kar.Risk Factors for Hepatocellular Carcinoma in India[J]. Journal of Clinical and Experimental Hepatology . 2014
  • 7Yan Li,Leilei Chen,Tim Hon Man Chan,Xin-Yuan Guan.Hepatocellular carcinoma: Transcriptome diversity regulated by RNA editing[J]. International Journal of Biochemistry and Cell Biology . 2013 (8)
  • 8Jie Ding,Shenglin Huang,Shunquan Wu,Yingjun Zhao,Linhui Liang,Mingxia Yan,Chao Ge,Jian Yao,Taoyang Chen,Dafang Wan,Hongyang Wang,Jianren Gu,Ming Yao,Jinjun Li,Hong Tu,Xianghuo He.Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nature Cell Biology . 2010
  • 9Li J,Shi W,Gao Y,Yang B,Jing X,Shan S,Wang Y,Du Z.Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma. Clinical Laboratory . 2013
  • 10Ji X,Zhang Q,Du Y,Liu W,Li Z,Hou X,et al.Somatic mutations,Viral integration and epigenetic modification in the evolution of hepatitis B Vivus-indured hepatocellular carcinoma. Current Genomics . 2014

共引文献2

同被引文献39

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部